Citation analysis for Seminar Briefings / Office of Health Economics

Seminar Briefings / Office of Health Economics

0.5

Impact Factor

0.22

5-Years IF

5-Years H index

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw data

	IF	AIF	IF5	DOC	CDO	CCU	CIF	CIT	D2Y	C2Y	D5Y	C5Y	%SC	CiY	II	AII
1990		0.11			0				0		0		(%)			0.06
1991		0.1			0				0		0		(%)			0.04
1992		0.1			0				0		0		(%)			0.05
1993		0.13			0				0		0		(%)			0.06
1994		0.14			0				0		0		(%)			0.06
1995		0.17			0				0		0		(%)			0.1
1996		0.22			0				0		0		(%)			0.09
1997		0.22			0				0		0		(%)			0.09
1998		0.24			0				0		0		(%)			0.12
1999		0.3		3	3				0		0		(%)			0.15
2000		0.36			3				3		3		(%)			0.14
2001		0.36			3				3		3		(%)			0.16
2002		0.37		1	4				0		3		(%)			0.18
2003		0.39		1	5				1		4		(%)			0.19
2004		0.4			5				2		5		(%)			0.18
2005		0.42			5				1		2		(%)			0.2
2006		0.45			5				0		2		(%)			0.19
2007		0.38			5				0		2		(%)			0.16
2008		0.39			5				0		1		(%)			0.17
2009		0.36			5				0		0		(%)			0.17
2010		0.34		2	7			2	0		0		(%)			0.15
2011	0.5	0.4	0.5	3	10	1	0.1	4	2	1	2	1	1 (25%)			0.19
2012	0.2	0.44	0.2	2	12	1	0.08		5	1	5	1	(%)			0.2
2013	0.2	0.49	0.14		12	1	0.08		5	1	7	1	(%)			0.2
2014		0.52	0.29	3	15	3	0.2	1	2		7	2	(%)	1	0.33	0.23
2015		0.54		3	18			3	3		10		(%)			0.24
2016		0.6		1	19				6		11		(%)			0.27
2017	0.5	0.64	0.22	2	21	3	0.14		4	2	9	2	(%)			0.28

IF:	Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for series in RePEc in year y
IF5:	Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CCU:	Cumulative number of citations to papers published until year y
CIF:	Cumulative impact factor
CIT:	Number of citations to papers published in year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series:

#	Year	Title	Cited
1	2011	Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?. (2011). Donaldson, C. In: Seminar Briefings. RePEc:ohe:sembri:000173. Full description at Econpapers \|\| Download paper	4
2	2015	A Framework for Payer Assessment of the Value of New Technologies: A US Approach. (2015). Pearson, S. In: Seminar Briefings. RePEc:ohe:sembri:001589. Full description at Econpapers \|\| Download paper	2
3	2010	Innovation in Medicines: Can We Value Progress?. (2010). Sussex, J. In: Seminar Briefings. RePEc:ohe:sembri:000219. Full description at Econpapers \|\| Download paper	2
4	2014	Can the US Afford to Ignore Cost-effectiveness Evidence?. (2014). Chambers, J. In: Seminar Briefings. RePEc:ohe:sembri:000074. Full description at Econpapers \|\| Download paper	1
5	2015	Multi-indication Pricing: Pros, Cons and Applicability to the UK. (2015). Towse, Adrian ; Mestre-Ferrandiz, J ; Pistollato, M ; Dellamano, R. In: Seminar Briefings. RePEc:ohe:sembri:001653. Full description at Econpapers \|\| Download paper	1

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited
1	2015	A Framework for Payer Assessment of the Value of New Technologies: A US Approach. (2015). Pearson, S. In: Seminar Briefings. RePEc:ohe:sembri:001589. Full description at Econpapers \|\| Download paper	2

Citing documents used to compute impact factor 2:

Year	Title
2017	Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework. (2017). Angelis, Aris ; Kanavos, Panos. In: Social Science & Medicine. RePEc:eee:socmed:v:188:y:2017:i:c:p:137-156. Full description at Econpapers \|\| Download paper
2017	Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784. Full description at Econpapers \|\| Download paper

Recent citations (cites in year: CiY)

Recent citations received in 2015

Year	Citing document

10 most frequent citing series

#	Series	Cites
1	Research Papers / Office of Health Economics	3
2	Seminar Briefings / Office of Health Economics	1
3	Social Science & Medicine / Elsevier	1
4	Consulting Reports / Office of Health Economics	1

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.